---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-001214"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T09:39:35.134546+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health interim CFO John Kallassy resigns; CEO becomes principal accounting officer

## Summary
- John Kallassy resigned as Interim CFO effective January 10, 2025, for personal reasons.
- CEO Dr. Sandra Milligan will serve as principal accounting officer until a permanent CFO is appointed.
- Board reinstated Dr. Milligan's full salary retroactive to December 16, 2024.

## SEC filing metadata
- accession: 0001493152-25-001214
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/0001493152-25-001214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-001214
- JSON: https://secwatch.observer/filing/0001493152-25-001214.json
- Plain text: https://secwatch.observer/filing/0001493152-25-001214.txt

## Key facts
- Executive change
  Sandra Milligan was appointed as principal accounting officer at Aspira Women's Health Inc..
  - Action: appointed as principal accounting officer
  - Role: principal accounting officer
  source text: The Company’s Chief Executive Officer, Dr. Sandra Milligan, will be the Company’s principal accounting officer for the present time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/0001493152-25-001214-index.htm
- Executive change
  John Kallassy resigned as Interim Chief Financial Officer at Aspira Women's Health Inc..
  - Action: resigned
  - Role: Interim Chief Financial Officer
  source text: accepted the resignation for personal reasons of John Kallassy, the Company’s Interim Chief Financial Officer, effective on January 10, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/0001493152-25-001214-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.